Creating Visibility for Clinical Trial Sites with Senior MSL Team ​

2 mins read
15 May 2024

Case Study (Global)

The Challenge

Creation of a small scale global MSL program to assist in aggregating quantitative data to support a product.​

Creation of a qualitative approach to leveraging MSLs to connect the patient journey to community experts and establish informal networks. ​

Create visibility for clinical trial sites, mapping influencer networks and bringing back medical insights to the organization. ​

Our Solution​

We recruit MSLs with a background in genetics, cell biology and who have similar past experience in building international networks within rare disease.​

Work collaboratively with USMA to develop a training program for product specific guidance, outlining a comprehensive onboarding schedule.  ​

Validate current list of HCPs and maintain an up-to-date list of HCPs, as determined by the client​

Support the clinical development program, and collection of insights from KOLs, on strategic initiatives conducted at prioritized accounts and/or institutions​.

The Results​

A global, influential team of rare disease experts​

2 MSLs hired (MD and PhD) – US and EU covering a broad outreach of research sites with a scalable model to adjust to more FTEs based on the client.​

MSLs are actively engaged on multiple functional areas of influence: ​

  • Actively involved in the global publication strategy   ​
  • Review and provide feedback on internal manuscripts ​
  • Attending relevant medical congresses and providing executive summaries for strategy​
  • Collaborating with CROs, specifically with CRAs and Global Project Lead​
  • Working compliantly and collaboratively with Global Head of Patient Advocacy ​
  • Support tracking/receipt confirmation of IP delivery to EAP sites ​
  • Actively participate in internal initiatives to help/support/inform key aspects of the clinical trial program and the clinical trial protocol ​